Antibiotic prophylaxis for transrectal prostate biopsy--a new strategy
Open Access
- 11 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 69 (12) , 3372-3378
Abstract
Fluoroquinolones are extensively used as prophylaxis for transrectal ultrasound-guided biopsy of the prostate (TRUBP). Emerging fluoroquinolone resistance and selection of multiresistant organisms warrant new prophylactic strategies. Pivmecillinam and amoxicillin/clavulanic acid have mutual synergistic activity and the combination of these agents has a broad coverage of the majority of microorganisms causing infectious complications after TRUBP and may be a valuable future prophylactic regimen. This was a retrospective cohort study of 2624 men that underwent TRUBP at a Danish university hospital. The patients were divided into three groups. Group 1 (n = 1220) received ciprofloxacin before TRUBP, Group 2 (n = 240) received a combination of pivmecillinam and amoxicillin/clavulanic acid before TRUBP and Group 3 (n = 1161) received an extended prophylaxis with pivmecillinam and amoxicillin/clavulanic acid before and for 2 days after TRUBP. One hundred and ten out of 148 (74.3%) post-TRUBP infections were caused by Escherichia coli, Klebsiella pneumoniae or Enterococcus faecalis. Group 3 with the extended prophylaxis with pivmecillinam and amoxicillin/clavulanic acid had a significantly lower rate of bacteraemia (0.9%) as compared with Group 1 (1.8%) and Group 2 (3.7%). A significant fall in the proportion of ESBL-producing Enterobacteriaceae was observed from the period when ciprofloxacin was used as prophylaxis (8.1%) compared with the subsequent period when pivmecillinam and amoxicillin/clavulanic acid was used (5.9%). The combination of pivmecillinam and amoxicillin/clavulanic acid is an attractive prophylaxis for TRUBP from a clinical, bacteriological and ecological point of view as compared with ciprofloxacin.Keywords
This publication has 41 references indexed in Scilit:
- The Impotent Certificate of NeedJournal of Urology, 2013
- Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized TrialEuropean Urology, 2012
- Fourteen years in resistanceInternational Journal of Antimicrobial Agents, 2012
- CUA guidelines on prostate biopsy methodologyCanadian Urological Association Journal, 2010
- UROSEPSIS AND BACTERAEMIA CAUSED BY ANTIBIOTIC‐RESISTANT ORGANISMS AFTER TRANSRECTAL ULTRASONOGRAPHY‐GUIDED PROSTATE BIOPSYBJU International, 2009
- Pharmacokinetics of inhaled colistin in patients with cystic fibrosis: authors' responseJournal of Antimicrobial Chemotherapy, 2006
- Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- The Effectiveness of a Short Perioperative Course with Pivampicillin/Pivmecillinam in Transurethral Prostatic Resection: Bacteriological ResultsScandinavian Journal of Infectious Diseases, 1986
- The Effectiveness of a Short Perioperative Course with Pivampicillin/Pivmecillinam in Transurethral Prostatic Resection: Clinical ResultsScandinavian Journal of Infectious Diseases, 1986
- Serum concentrations and penetration into prostate of mecillinam and ampicillinCurrent Medical Research and Opinion, 1984